Marker Therapeutics Statistics
Total Valuation
MRKR has a market cap or net worth of $46.74 million. The enterprise value is $35.41 million.
| Market Cap | 46.74M |
| Enterprise Value | 35.41M |
Important Dates
The next estimated earnings date is Monday, August 12, 2024, after market close.
| Earnings Date | Aug 12, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
MRKR has 8.92 million shares outstanding. The number of shares has increased by 2.07% in one year.
| Shares Outstanding | 8.92M |
| Shares Change (YoY) | +2.07% |
| Shares Change (QoQ) | +1.92% |
| Owned by Insiders (%) | 12.20% |
| Owned by Institutions (%) | 22.78% |
| Float | 6.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 14.07 |
| Forward PS | n/a |
| PB Ratio | 3.96 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 10.66 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.12, with zero debt.
| Current Ratio | 6.12 |
| Quick Ratio | 5.72 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -36.80% and return on invested capital (ROIC) is -108.76%.
| Return on Equity (ROE) | -36.80% |
| Return on Assets (ROA) | -31.20% |
| Return on Capital (ROIC) | -108.76% |
| Revenue Per Employee | $415,107 |
| Profits Per Employee | -$707,758 |
| Employee Count | 8 |
| Asset Turnover | 0.18 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, MRKR has paid $3,675 in taxes.
| Income Tax | 3,675 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +45.96% in the last 52 weeks. The beta is 1.60, so MRKR's price volatility has been higher than the market average.
| Beta (5Y) | 1.60 |
| 52-Week Price Change | +45.96% |
| 50-Day Moving Average | 4.21 |
| 200-Day Moving Average | 4.06 |
| Relative Strength Index (RSI) | 66.15 |
| Average Volume (20 Days) | 37,355 |
Short Selling Information
The latest short interest is 93,312, so 1.05% of the outstanding shares have been sold short.
| Short Interest | 93,312 |
| Short Previous Month | 59,034 |
| Short % of Shares Out | 1.05% |
| Short % of Float | 1.38% |
| Short Ratio (days to cover) | 6.10 |
Income Statement
In the last 12 months, MRKR had revenue of $3.32 million and -$5.66 million in losses. Loss per share was -$0.64.
| Revenue | 3.32M |
| Gross Profit | 3.32M |
| Operating Income | -12.82M |
| Pretax Income | -5.66M |
| Net Income | -5.66M |
| EBITDA | -6.63M |
| EBIT | -5.66M |
| Loss Per Share | -$0.64 |
Balance Sheet
The company has $11.32 million in cash and no debt, giving a net cash position of $11.32 million or $1.27 per share.
| Cash & Cash Equivalents | 11.32M |
| Total Debt | n/a |
| Net Cash | 11.32M |
| Net Cash Per Share | $1.27 |
| Equity (Book Value) | 11.79M |
| Book Value Per Share | 1.32 |
| Working Capital | 11.79M |
Cash Flow
In the last 12 months, operating cash flow was -$14.39 million and capital expenditures $112,608, giving a free cash flow of -$14.28 million.
| Operating Cash Flow | -14.39M |
| Capital Expenditures | 112,608 |
| Free Cash Flow | -14.28M |
| FCF Per Share | -$1.60 |
Margins
Gross margin is 100.00%, with operating and profit margins of -386.07% and -170.50%.
| Gross Margin | 100.00% |
| Operating Margin | -386.07% |
| Pretax Margin | -170.39% |
| Profit Margin | -170.50% |
| EBITDA Margin | -199.65% |
| EBIT Margin | -170.39% |
| FCF Margin | -429.89% |
Dividends & Yields
MRKR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.07% |
| Shareholder Yield | -2.07% |
| Earnings Yield | -12.11% |
| FCF Yield | -30.55% |
Analyst Forecast
The average price target for MRKR is $11.00, which is 109.92% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 109.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | -9.07% |
Stock Splits
The last stock split was on January 27, 2023. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jan 27, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
MRKR has an Altman Z-Score of -31.49 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -31.49 |
| Piotroski F-Score | 2 |